- Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
-
Braschi-Amirfarzan M, Tirumani S, Hodi FS, Nishino M
- KMID: 2468121
- Korean J Radiol.
- 2017 Feb;18(1):42-53.
- doi: 10.3348/kjr.2017.18.1.42
Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome of Treatment with Infliximab in Crohn's Disease: A Single-Center Experience
-
Kim YJ, Kim JW, Lee CK, Park HJ, Shim JJ, Jang JY, Dong SH, Kim HJ, Kim BH, Chang YW
- KMID: 1501649
- Korean J Gastroenterol.
- 2013 May;61(5):270-278.
- doi: 10.4166/kjg.2013.61.5.270
BACKGROUND/AIMS: Our aim was to assess the long-term data regarding efficacy and safety of infliximab (IFX) treatment for refractory Crohn's disease (CD) patients in our tertiary teaching hospital. METHODS: We have... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Treatment with Infliximab in Crohn's Disease: the Experience of Single Center in Korea
-
Choi KD, Song HJ, Kim JS, Jung HC, Song IS
- KMID: 1767509
- Korean J Gastroenterol.
- 2005 Jul;46(1):48-55.
BACKGROUND/AIMS: Infliximab has been shown to be effective and safe for treating refractory luminal and fistulizing Crohn's disease (CD). The aim of this study was to report the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab(TM)) in High-Risk Patients with Percutaneous Coronary Intervention
-
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y
- KMID: 724253
- Yonsei Med J.
- 2008 Jun;49(3):389-399.
- doi: 10.3349/ymj.2008.49.3.389
PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab(TM). We expected to obtain same results as with ReoPro(R) in improving... -
- CITED
-
- Close
- SHARE
-
- Close
- The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
-
Lee SY, Kim JG, Joe SG, Chung H, Yoon YH
- KMID: 1099002
- Korean J Ophthalmol.
- 2008 Jun;22(2):92-99.
- doi: 10.3341/kjo.2008.22.2.92
PURPOSE: To evaluate the efficacy and safety of intravitreal bevacizumab for polypoidal choroidal vasculopathy (PCV). METHODS: In this retrospective interventional pilot study, 12 eyes of 11 patients with active... -
- CITED
-
- Close
- SHARE
-
- Close
